To hear about similar clinical trials, please enter your email below

Trial Title: Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine

NCT ID: NCT06263387

Condition: AML, Adult

Conditions: Official terms:
Leukemia, Myeloid, Acute

Study type: Observational [Patient Registry]

Overall status: Recruiting

Study design:

Time perspective: Cross-Sectional

Summary: Following the results of the phase 1b and the phase 3 studies, Venetoclax/Azacitidine (VEN/AZA) was available in France for newly diagnosed AML patients ineligible-IC patients through the early access program the so-called ATU program. Venetoclax (VEN) has been available in France through the ATU since Feb 2021 and through the current post-ATU schema from the point of marketing authorization approval and up to the pending publication of reimbursement and price. Between February 15, 2021, and June 30, 2021, 285 requests for ATU were made to the pharmaceutical company (Abbvie) and led to the initiation of treatment of more than 230 patients. At the end of ATU period, all these 230 ATU patients continued to be treated by VEN/AZA as part of the current post-ATU period. Healthcare professionals and health care decision makers need real world data to better understand the benefit/risk profile of treatment. Early access to treatment in France is close to real-life setting condition.

Criteria for eligibility:

Study pop:
Adult Patients with de novo AML, ineligible for intensive chemotherapy, which received VENAZA in the ATU program between 02/15/2021 and 06/30/2021

Sampling method: Probability Sample
Criteria:
Inclusion Criteria: - Adult patients - treatment with VEN-AZA for newly diagnosed AML and ineligible to intensive chemotherapy - Treatment in the named-patients program (ATU) Exclusion Criteria: - Treatment with VEN-AZA for previously treated AML - Prior treatment for preexisting hematological malignancies other that AML, including AZA is not an exclusion criteria - HYDROXYCARBAMIDE given for AML is not an exclusion criteria - AZA started before VEN for AML is not an exclusion criteria - Opposition to data collection

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Amiens CHU

Address:
City: Amiens
Country: France

Status: Not yet recruiting

Contact:
Last name: Delphine Lebon, Dr
Email: lebon.delphine@chu-amiens.fr

Facility:
Name: Angers CHU

Address:
City: Angers
Country: France

Status: Not yet recruiting

Contact:
Last name: Mathilde Hunault, Prof
Email: mahunault@chu-angers.fr

Facility:
Name: Avignon CH

Address:
City: Avignon
Country: France

Status: Not yet recruiting

Contact:
Last name: Safia Chebrek, dr
Email: chebrek.safia@ch-avignon.fr

Facility:
Name: Bayonne CH

Address:
City: Bayonne
Country: France

Status: Not yet recruiting

Contact:
Last name: Anne Banos, Dr
Email: abanos@ch-cotebasque.fr

Facility:
Name: Besançon CHU

Address:
City: Besançon
Country: France

Status: Recruiting

Contact:
Last name: Yohann Desbrosses, Dr
Email: ydesbrosses@chu-besancon.fr

Facility:
Name: Brest CHU

Address:
City: Brest
Country: France

Status: Not yet recruiting

Contact:
Last name: Gaelle Guillerm, Dr
Email: gaelle.guillerm@chu-brest.fr

Facility:
Name: Caen CHU

Address:
City: Caen
Country: France

Status: Not yet recruiting

Contact:
Last name: sylvain Chantepie, Dr
Email: chantepie-s@chu-caen.fr

Facility:
Name: CERGY PONTOISE - CH René Dubos

Address:
City: Cergy-Pontoise
Country: France

Status: Not yet recruiting

Contact:
Last name: ioana Vaida, Dr
Email: ioana.vaida@ght-novo.fr

Facility:
Name: Hôpital d'Instruction des Armées PERCY

Address:
City: Clamart
Country: France

Status: Not yet recruiting

Contact:
Last name: Pierre Arnautou, Dr
Email: pierre.arnautou@intradef.gouv.fr

Facility:
Name: CHU Estaing

Address:
City: Clermont-Ferrand
Country: France

Status: Not yet recruiting

Contact:
Last name: Gaspar Aspas Requena, MD
Email: gaspasrequena@chu-clermontferrand.fr

Facility:
Name: Corbeil-Essonnes - Ch Sud Francilien

Address:
City: Corbeil-Essonnes
Country: France

Status: Not yet recruiting

Contact:
Last name: Stephanie Haiat, Dr
Email: stephanie.haiat@chsf.fr

Facility:
Name: Créteil CHU HENRI MONDOR

Address:
City: Créteil
Country: France

Status: Not yet recruiting

Contact:
Last name: Cécile Pautas, Dr
Email: cecile.pautas@aphp.fr

Facility:
Name: Dijon CHU

Address:
City: Dijon
Country: France

Status: Not yet recruiting

Contact:
Last name: Marie-Lorraine chretien, Dr
Email: marie-lorraine.chretien@chu-dijon.fr

Facility:
Name: Grenoble CHU

Address:
City: Grenoble
Country: France

Status: Not yet recruiting

Contact:
Last name: Martin Carré, Dr
Email: MCarre1@chu-grenoble.fr

Facility:
Name: Le Mans CH

Address:
City: Le Mans
Country: France

Status: Not yet recruiting

Contact:
Last name: Kamel Laribi, Dr
Email: klaribi@ch-lemans.fr

Facility:
Name: CHU Lille

Address:
City: Lille
Country: France

Status: Not yet recruiting

Contact:
Last name: Céline Berthon, Dr
Email: celine.berthon@chu-lille.fr

Facility:
Name: Limoges CHU

Address:
City: Limoges
Country: France

Status: Not yet recruiting

Contact:
Last name: Pascal Turlure, Dr
Email: pascal.turlure@chu-limoges.fr

Facility:
Name: Lyon sud CHU

Address:
City: Lyon
Country: France

Status: Not yet recruiting

Contact:
Last name: Mael Heiblig, Pr
Email: mael.heiblig@chu-lyon.fr

Facility:
Name: Marseille IPC

Address:
City: Marseille
Country: France

Status: Not yet recruiting

Contact:
Last name: Sylvain GARCIAZ, Dr
Email: GARCIAZS@ipc.unicancer.fr

Facility:
Name: Meaux CH de l'Est francilien

Address:
City: Meaux
Country: France

Status: Not yet recruiting

Contact:
Last name: Jamilé Frayfer, Dr
Email: jfrayfer@ghef.fr

Facility:
Name: METZ-THIONVILLE CHR- Hôpital de Mercy

Address:
City: Metz
Country: France

Status: Not yet recruiting

Contact:
Last name: Houria Debarri, Dr
Email: h.debarri@chr-metz-thionville.fr

Facility:
Name: Montpellier - Chu Saint Eloi

Address:
City: Montpellier
Country: France

Status: Not yet recruiting

Contact:
Last name: Ludovic Gabellier, Dr
Email: l-gabellier@chu-montpellier.fr

Facility:
Name: Nantes CHU

Address:
City: Nantes
Country: France

Status: Not yet recruiting

Contact:
Last name: Pierre Peterlin, Dr
Email: pierre.peterlin@chu-nantes.fr

Facility:
Name: Nice CHU

Address:
City: Nice
Country: France

Status: Not yet recruiting

Contact:
Last name: Thomas Cluzeau, Prof
Email: cluzeau.t@chu-nice.fr

Facility:
Name: Nimes CHU

Address:
City: Nîmes
Country: France

Status: Not yet recruiting

Contact:
Last name: Eric Jourdan, Dr
Email: eric.jourdan@chu-nimes.fr

Facility:
Name: Paris La Pitié salpetrière

Address:
City: Paris
Country: France

Status: Not yet recruiting

Contact:
Last name: Madalina Uzunov, Dr
Email: madalina.uzunov@psl.aphp.fr

Facility:
Name: Paris Necker

Address:
City: Paris
Country: France

Status: Not yet recruiting

Contact:
Last name: Ambroise Marcais, Dr
Email: ambroise.marcais@aphp.fr

Facility:
Name: Paris Saint Louis

Address:
City: Paris
Country: France

Status: Not yet recruiting

Contact:
Last name: Emmanuel Raffoux, Prof
Email: emmanuel.raffoux@aphp.fr

Facility:
Name: Bordeaux CHU

Address:
City: Pessac
Country: France

Status: Recruiting

Contact:
Last name: Pierre-Yves Dumas, Prof
Email: pierre-yves.dumas@chu-bordeaux.fr

Facility:
Name: Reims CHU

Address:
City: Reims
Country: France

Status: Not yet recruiting

Contact:
Last name: Chantal Himberlin, Dr
Email: chimberlin@chu-reims.fr

Facility:
Name: Rennes CHU

Address:
City: Rennes
Country: France

Status: Not yet recruiting

Contact:
Last name: tony Marchand, Dr
Email: tony.marchand@chu-rennes.fr

Facility:
Name: roubaix CH

Address:
City: Roubaix
Country: France

Status: Not yet recruiting

Contact:
Last name: Mathieu Wemeau, Dr
Email: mathieu.wemeau@ch-roubaix.fr

Facility:
Name: Centre de Lutte Contre le Cancer H. Becquerel

Address:
City: Rouen
Country: France

Status: Not yet recruiting

Contact:
Last name: Emilie Lemasle, Dr
Email: emilie.lemasle@chb.unicancer.fr

Facility:
Name: Institut de Cancérologie Lucien Neuwirth

Address:
City: Saint-Priest-en-Jarez
Country: France

Status: Recruiting

Contact:
Last name: Emmanuelle tavernier, Dr
Email: emmanuelle.tavernier@icloire.fr

Facility:
Name: Saint Quentin CH

Address:
City: Saint-Quentin
Country: France

Status: Not yet recruiting

Contact:
Last name: reda Garidi, Dr
Email: r.garidi@ch-stquentin.fr

Facility:
Name: ICANS - Institut de cancérologie de strasbourg europe

Address:
City: Strasbourg
Country: France

Status: Not yet recruiting

Contact:
Last name: Célestine Simand, Dr
Email: c.simand@icans.eu

Facility:
Name: Toulouse - IUCT Oncopole - Service d'Hématologie

Address:
City: Toulouse
Country: France

Status: Recruiting

Contact:
Last name: Toulouse - IUCT Oncopole - S d'Hématologie, Pr
Email: recher.christian@iuct-oncopole.fr

Facility:
Name: Tours CHU

Address:
City: Tours
Country: France

Status: Not yet recruiting

Contact:
Last name: Alban Villate, Dr
Email: a.villate@chu-tours.fr

Facility:
Name: Troyes CH

Address:
City: Troyes
Country: France

Status: Not yet recruiting

Contact:
Last name: Alberto santagostino, Dr
Email: alberto.santagostino@ch-troyes.fr

Facility:
Name: Nancy CHU

Address:
City: vandoeuvre les Nancy
Country: France

Status: Not yet recruiting

Contact:
Last name: Caroline Bonmati, Dr
Email: c.bonmati@chu-nancy.fr

Facility:
Name: Versailles CH

Address:
City: Versailles
Country: France

Status: Not yet recruiting

Contact:
Last name: Juliette Lambert, Dr
Email: jlambert@ch-versailles.fr

Facility:
Name: Villejuif IGR

Address:
City: Villejuif
Country: France

Status: Not yet recruiting

Contact:
Last name: Florence Pasquier, Dr
Email: florence.pasquier@gustaveroussy.fr

Start date: July 4, 2024

Completion date: March 30, 2025

Lead sponsor:
Agency: French Innovative Leukemia Organisation
Agency class: Other

Collaborator:
Agency: Acute Leukemia French Association
Agency class: Other

Source: French Innovative Leukemia Organisation

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06263387

Login to your account

Did you forget your password?